Over the weekend, three pieces of good news occurred that should be quite beneficial to our portfolios over the next 12 months and hopefully sooner too.  First, the Moderna vaccine was approved and will start to be used on Monday.  This is another MRNA vaccine like the one from Pfizer, but it doesn’t require the...Read More